Elizabeth Hurlburt - 12 Jan 2024 Form 4/A Insider Report for CorMedix Inc. (CRMD)

Role
EVP, Head of Clinical Ops.
Signature
/s/ Elizabeth Hurlburt
Issuer symbol
CRMD
Transactions as of
12 Jan 2024
Net transactions value
$0
Form type
4/A
Filing time
18 Jan 2024, 16:53:09 UTC
Date Of Original Report
17 Jan 2024
Previous filing
18 Jan 2023
Next filing
18 Nov 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CRMD Common Stock 45,397 12 Jan 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On January 17, 2024, the reporting person filed a Form 4 which inadvertently reported that, following the reported transactions, the reporting person directly beneficially owned 53,397 shares of CorMedix Inc. common stock ("Common Stock"). As reported in this amendment, the reporting person directly beneficially owns 45,397 shares of Common Stock.